[Biosynthesis of PGE2 and PGF2 alpha in normal and pathological human synovial fluid].
The biosynthesis capacity of PGE2 and PGF2 alpha in normal and pathological (rheumatoid arthritis and osteo-arthrosis) synovialis was studied using the radio-immunological method, simultaneously on homogenized tissues and the microsome fraction, with or without addition of exogenous arachidonic acid. Among the results obtained, the most significant concern rheumatoid polyarthritis: a net increase in PGF2 alpha and especially in PGE2, more pronounced in the homogenized emulsion than in the microsomial fraction. Exogenous arachidonic acid increases the biosynthesis capacity of the PG. The prospective interest of this model is underlined: the possible introduction in the incubation medium of various drugs, making it possible to study the various factors taking part in the biosynthesis of PG (phospholipase A2 and prostaglandin-synthetase).
D001095:Arachidonic Acids / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000378:metabolism; D006801:Humans; D008861:Microsomes / Q000378:metabolism; D010003:Osteoarthritis / Q000378:metabolism; D011458:Prostaglandins E / Q000096:biosynthesis*; D011460:Prostaglandins F / Q000096:biosynthesis*; D011863:Radioimmunoassay; D013582:Synovial Fluid / Q000378:metabolism*
D001095:Arachidonic Acids; D011458:Prostaglandins E; D011460:Prostaglandins F
Biosynthèse de PGE2 et PGF2 alpha dans les synoviales humaines normales et pathologiques.